JENNIFER KILBY: Open Payments
NPI 1902291040 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 29 payments from 9 companies in 2025. Trend: 2023 $97 · 2024 $380 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $219 |
| Phathom Pharmaceuticals, Inc. | 6 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Boston Scientific Corporation | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: Wegovy, VOQUEZNA, Rybelsus, REXULTI, General - Erectile Dysfunction, AIRSUPRA, TRINTELLIX, Ozempic.
Industry payments across TN — which companies pay providers there.
